DevicePMAs@therightstef:P010018_S005 JSONTXT

{"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":43,"end":49},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62103"},{"id":"T3","span":{"begin":71,"end":80},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53288"},{"id":"T4","span":{"begin":81,"end":90},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61367"},{"id":"T5","span":{"begin":94,"end":100},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C102533"},{"id":"T6","span":{"begin":133,"end":137},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48927"},{"id":"T7","span":{"begin":165,"end":168},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12401"},{"id":"T8","span":{"begin":243,"end":252},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15368"},{"id":"T9","span":{"begin":301,"end":304},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},{"id":"T10","span":{"begin":327,"end":337},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25356"},{"id":"T11","span":{"begin":338,"end":347},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54072"},{"id":"T12","span":{"begin":370,"end":375},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25629"},{"id":"T13","span":{"begin":408,"end":414},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25446"},{"id":"T14","span":{"begin":572,"end":584},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54732"},{"id":"T15","span":{"begin":608,"end":615},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54625"},{"id":"T16","span":{"begin":643,"end":651},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25487"},{"id":"T17","span":{"begin":652,"end":655},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12401"},{"id":"T18","span":{"begin":656,"end":665},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37934"},{"id":"T19","span":{"begin":670,"end":678},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25167"},{"id":"T20","span":{"begin":703,"end":706},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12401"},{"id":"T21","span":{"begin":707,"end":716},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37934"},{"id":"T22","span":{"begin":721,"end":725},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48927"}],"text":"Approval for the viewpoint ck system. The device is indicated for the temporary induction of myopia (-1.00 d to -2.00 d) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 to 2.25 d, in patients: 1) 40 years of age of greater; 2) with a documented stability of refraction for the prior 12 months, as demonstrated by a change of \u003c0.50 d in spherical and cylindrical components of the manifest refraction; 3) with \u003c=0.75 d of cycloplegic refractive cylinder; and 4) with a successful preoperative trial of monovision or history of monovision wear (i. e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision)."}

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T6","span":{"begin":289,"end":315},"obj":"age_range"},{"id":"T9","span":{"begin":289,"end":291},"obj":"age_start"},{"id":"T8","span":{"begin":292,"end":297},"obj":"age_start_unit"},{"id":"T7","span":{"begin":308,"end":315},"obj":"age_end"}],"text":"Approval for the viewpoint ck system. The device is indicated for the temporary induction of myopia (-1.00 d to -2.00 d) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 to 2.25 d, in patients: 1) 40 years of age of greater; 2) with a documented stability of refraction for the prior 12 months, as demonstrated by a change of \u003c0.50 d in spherical and cylindrical components of the manifest refraction; 3) with \u003c=0.75 d of cycloplegic refractive cylinder; and 4) with a successful preoperative trial of monovision or history of monovision wear (i. e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision)."}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":289,"end":291},"obj":"age_start"},{"id":"T2","span":{"begin":292,"end":297},"obj":"age_start_unit"},{"id":"T3","span":{"begin":308,"end":315},"obj":"age_end"},{"id":"T4","span":{"begin":289,"end":315},"obj":"age_range"}],"text":"Approval for the viewpoint ck system. The device is indicated for the temporary induction of myopia (-1.00 d to -2.00 d) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 to 2.25 d, in patients: 1) 40 years of age of greater; 2) with a documented stability of refraction for the prior 12 months, as demonstrated by a change of \u003c0.50 d in spherical and cylindrical components of the manifest refraction; 3) with \u003c=0.75 d of cycloplegic refractive cylinder; and 4) with a successful preoperative trial of monovision or history of monovision wear (i. e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision)."}

{"project":"PMA_age_indications","denotations":[{"id":"T9","span":{"begin":289,"end":291},"obj":"age_start"},{"id":"T6","span":{"begin":289,"end":315},"obj":"age_range"},{"id":"T8","span":{"begin":292,"end":297},"obj":"age_start_unit"},{"id":"T7","span":{"begin":308,"end":315},"obj":"age_end"}],"text":"Approval for the viewpoint ck system. The device is indicated for the temporary induction of myopia (-1.00 d to -2.00 d) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 to 2.25 d, in patients: 1) 40 years of age of greater; 2) with a documented stability of refraction for the prior 12 months, as demonstrated by a change of \u003c0.50 d in spherical and cylindrical components of the manifest refraction; 3) with \u003c=0.75 d of cycloplegic refractive cylinder; and 4) with a successful preoperative trial of monovision or history of monovision wear (i. e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision)."}

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T9","span":{"begin":289,"end":291},"obj":"age_start"},{"id":"T6","span":{"begin":289,"end":315},"obj":"age_range"},{"id":"T7","span":{"begin":308,"end":315},"obj":"age_end"},{"id":"T8","span":{"begin":292,"end":297},"obj":"age_start_unit"}],"text":"Approval for the viewpoint ck system. The device is indicated for the temporary induction of myopia (-1.00 d to -2.00 d) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 to 2.25 d, in patients: 1) 40 years of age of greater; 2) with a documented stability of refraction for the prior 12 months, as demonstrated by a change of \u003c0.50 d in spherical and cylindrical components of the manifest refraction; 3) with \u003c=0.75 d of cycloplegic refractive cylinder; and 4) with a successful preoperative trial of monovision or history of monovision wear (i. e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision)."}